CIC
GILD icon

Carnegie Investment Counsel’s Gilead Sciences GILD Stock Holding History

Carnegie Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.45M Buy
35,216
+358
+1% +$47.2K 0.09% 177
2026
Q1 		$4.86M Sell
34,858
-521
-1% -$73K 0.09% 179
2025
Q4 		$4.34M Buy
35,379
+40
+0.1% +$4.86K 0.08% 188
2025
Q3 		$3.92M Buy
35,339
+776
+2% +$88.2K 0.07% 195
2025
Q2 		$3.83M Buy
34,563
+2,065
+6% +$220K 0.08% 187
2025
Q1 		$3.43M Buy
32,498
+102
+0.3% +$10.5K 0.08% 184
2024
Q4 		$2.99M Sell
32,396
-152
-0.5% -$13.7K 0.09% 175
2024
Q3 		$2.73M Buy
32,548
+1,173
+4% +$89.5K 0.08% 184
2024
Q2 		$2.15M Buy
31,375
+426
+1% +$28.4K 0.07% 200
2024
Q1 		$2.27M Buy
30,949
+1,079
+4% +$83K 0.07% 199
2023
Q4 		$2.42M Sell
29,870
-349
-1% -$27.2K 0.08% 189
2023
Q3 		$2.26M Buy
30,219
+4,658
+18% +$358K 0.09% 189
2023
Q2 		$1.97M Buy
25,561
+842
+3% +$67.2K 0.07% 204
2023
Q1 		$2.05M Sell
24,719
-397
-2% -$32.9K 0.08% 203
2022
Q4 		$2.16M Sell
25,116
-1,323
-5% -$105K 0.09% 197
2022
Q3 		$1.63M Buy
26,439
+19,805
+299% +$1.25M 0.08% 208
2022
Q2 		$410K Buy
6,634
+609
+10% +$37.7K 0.02% 361
2022
Q1 		$358K Sell
6,025
-321
-5% -$20.5K 0.01% 391
2021
Q4 		$461K Buy
6,346
+682
+12% +$47K 0.02% 364
2021
Q3 		$396K Hold
5,664
– – 0.01% 349
2021
Q2 		$390K Sell
5,664
-521
-8% -$34.8K 0.01% 354
2021
Q1 		$400K Sell
6,185
-2,256
-27% -$145K 0.02% 340
2020
Q4 		$492K Sell
8,441
-250
-3% -$15.1K 0.02% 304
2020
Q3 		$549K Sell
8,691
-567
-6% -$39.3K 0.03% 276
2020
Q2 		$712K Buy
9,258
+1,094
+13% +$83.8K 0.04% 240
2020
Q1 		$610K Sell
8,164
-1,245
-13% -$86K 0.04% 247
2019
Q4 		$611K Sell
9,409
-2,505
-21% -$163K 0.04% 280
2019
Q3 		$755K Sell
11,914
-706
-6% -$46.2K 0.05% 239
2019
Q2 		$853K Sell
12,620
-666
-5% -$43.8K 0.06% 233
2019
Q1 		$864K Buy
13,286
+4,601
+53% +$306K 0.06% 225
2018
Q4 		$543K Buy
8,685
+370
+4% +$25.9K 0.05% 247
2018
Q3 		$578K Sell
8,315
-534
-6% -$40.3K 0.05% 234
2018
Q2 		$684K Sell
8,849
-1,377
-13% -$97.2K 0.05% 243
2018
Q1 		$677K Sell
10,226
-539
-5% -$42.8K 0.06% 226
2017
Q4 		$891K Buy
10,765
+1,612
+18% +$122K 0.08% 218
2017
Q3 		$734K Buy
9,153
+600
+7% +$45.9K 0.09% 213
2017
Q2 		$649K Sell
8,553
-630
-7% -$41.9K 0.08% 217
2017
Q1 		$615K Sell
9,183
-27,691
-75% -$1.95M 0.08% 214
2016
Q4 		$2.8M Sell
36,874
-3,653
-9% -$272K 0.37% 79
2016
Q3 		$2.94M Buy
40,527
+4,126
+11% +$335K 0.42% 71
2016
Q2 		$2.98M Buy
36,401
+1,030
+3% +$91.4K 0.42% 75
2016
Q1 		$3.25M Buy
35,371
+1,430
+4% +$129K 0.5% 65
2015
Q4 		$2.82M Buy
33,941
+1,892
+6% +$197K 0.49% 62
2015
Q3 		$3.55M Buy
32,049
+2,872
+10% +$319K 0.61% 54
2015
Q2 		$3.42M Buy
29,177
+1,780
+6% +$195K 0.6% 59
2015
Q1 		$2.8M Buy
27,397
+575
+2% +$58.4K 0.48% 71
2014
Q4 		$2.74M Buy
26,822
+12,424
+86% +$1.28M 0.51% 68
2014
Q3 		$1.53M Buy
14,398
+365
+3% +$35.7K 0.31% 95
2014
Q2 		$1.16M Buy
14,033
+1,611
+13% +$125K 0.26% 99
2014
Q1 		$880K Buy
12,422
+532
+4% +$41.7K 0.23% 100
2013
Q4 		$893K Sell
11,890
-366
-3% -$25.5K 0.24% 102
2013
Q3 		$771K Sell
12,256
-134
-1% -$8.01K 0.24% 103
2013
Q2 		$635K Buy
+12,390
New +$646K 0.21% 114

Other funds holding GILD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Carnegie Investment Counsel's GILD Position: Q2 2026 in Review

Carnegie Investment Counsel increased its Gilead Sciences (GILD) stake by 1% in Q2 2026, buying an estimated $47.2K and bringing the position to 35,216 shares worth $4.45M. The position accounts for 0.09% of the portfolio, ranked #177.

Carnegie Investment Counsel first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.86M in Q1 2026. 1,071 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Carnegie Investment Counsel held 35,216 shares of Gilead Sciences worth $4.45M as of Q2 2026.
  • Carnegie Investment Counsel bought 358 Gilead Sciences shares in Q2 2026, an estimated $47.2K.
  • Gilead Sciences made up 0.09% of Carnegie Investment Counsel's portfolio in Q2 2026, its #177 holding.
  • Carnegie Investment Counsel first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Carnegie Investment Counsel's Gilead Sciences position peaked at $4.86M in Q1 2026.
  • 1,071 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.